Darzalex Faspro (Daratumumab) 1800mg Injection PSP

Description

Daratumumab, known commercially as Darzalex Faspro Injection, is a prescription medication available through authorized healthcare providers. Patients can access Darzalex Faspro Injection via licensed physicians, hospital treatment centers, and certified medical pharmacies that meet regulatory requirements.  

In May 2018, the US Food and Drug Administration (FDA) approved daratumumab for use in combination with bortezomib, melphalan and prednisone to include the treatment of people with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.

In the European Union it is indicated as monotherapy for the treatment of adults with relapsed and refractory multiple myeloma, whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who have demonstrated disease progression on the last therapy.

Which areas or states do you supply to?

Darzalex Faspro (Daratumumab) 1800mg Injection PSP is available in following cities in India – Mumbai, Delhi, Gurgaon, Noida, Bengaluru, Hyderabad, Ahmedabad, Chennai, Kolkata, Surat, Pune, Jaipur, Lucknow, Kanpur, Gurgaon, Punjab, Nagpur, Indore, Thane, Bhopal, Visakhapatnam, Pimpri-Chinchwad, Patna, Vadodara, Ghaziabad, Ludhiana, Agra, Nashik, Faridabad, Meerut, Rajkot, Kalyan-Dombivli, Vasai-Virar, Varanasi, Srinagar, Aurangabad, Dhanbad, Amritsar, Navi Mumbai, Prayagraj, Howrah, Ranchi, Jabalpur, Gwalior, Coimbatore, Vijayawada, Jodhpur, Madurai, Raipur, Kota, etc.

For large institutional or inter-state distribution, please contact our sales department for region-specific arrangements.